Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04510584
Title Maintenance Treatment With Bevacizumab and Atezolizumab for Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors University Health Network, Toronto

peritoneum cancer

fallopian tube cancer

ovarian serous carcinoma

endometrioid ovary carcinoma


Atezolizumab + Bevacizumab

Age Groups: adult | senior
Covered Countries CAN

Additional content available in CKB BOOST